Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 57.89B 8.55B 7.49B 6.88B 6.42B 12.16B 814B 12.32B 82.63B 32.11B 401B 32.1B 31.4B 1,379B | P/E 2026 * |
42.6x | P/E 2027 * | 35.2x |
|---|---|---|---|---|---|
| Enterprise Value | 52.81B 7.8B 6.83B 6.27B 5.85B 11.1B 743B 11.24B 75.38B 29.3B 365B 29.29B 28.65B 1,258B | EV / Sales 2026 * |
6.56x | EV / Sales 2027 * | 5.6x |
| Free-Float |
61.14% | Yield 2026 * |
0.89% | Yield 2027 * | 1.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rui Yang
CEO | Chief Executive Officer | 49 | 19/01/2022 |
Hao Hong
CEO | Chief Executive Officer | 70 | 07/10/1998 |
Da Zhang
DFI | Director of Finance/CFO | 45 | 07/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Hao Hong
CHM | Chairman | 70 | 07/10/1998 |
Rui Yang
BRD | Director/Board Member | 49 | 18/07/2011 |
Xin Yi Hou
BRD | Director/Board Member | 66 | 29/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.86B | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +3.86% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.89% | +4.92% | +31.10% | +56.12% | 411.08B | |
| Weighted average by Cap. | +2.24% | +5.54% | +41.79% | +80.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.05B 1.19B 1.04B 957M 892M 1.69B 113B 1.71B 11.49B 4.47B 55.7B 4.46B 4.37B 192B | 9.56B 1.41B 1.24B 1.14B 1.06B 2.01B 134B 2.03B 13.64B 5.3B 66.13B 5.3B 5.18B 228B |
| Net income | 1.41B 208M 182M 167M 156M 296M 19.78B 299M 2.01B 780M 9.73B 780M 763M 33.51B | 1.72B 253M 222M 204M 190M 360M 24.12B 365M 2.45B 951M 11.87B 951M 930M 40.87B |
| Net Debt | -5.08B -750M -657M -603M -563M -1.07B -71.42B -1.08B -7.25B -2.82B -35.14B -2.82B -2.76B -121B | -4.41B -651M -570M -523M -488M -926M -61.95B -938M -6.29B -2.44B -30.48B -2.44B -2.39B -105B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
